The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

These recommendations encompass advances in the assessment, diagnosis, monitoring, general approaches to management, non-pharmacological and pharmacological management of systemic lupus erythematosus, organ-specific treatment including lupus nephritis and cutaneous lupus erythematosus, as well as the delivery of care in the context of the UK healthcare system.